Clinical trial
Study of Depakote for Behavioral and Psychological Symptoms in Dementia
NCT00197834 · Hearthstone Alzheimer Care, Industry · Unknown status
Key facts
| NCT number | NCT00197834 |
|---|---|
| Title | Study of Depakote for Behavioral and Psychological Symptoms in Dementia |
| Official title | An Open-Label Prospective Study of Depakote for Behavioral and Psychological Symptoms in Dementia (BPSD): Use Alone and in Co-Prescription With Atypical Antipsychotic Medications |
| Lead sponsor | Hearthstone Alzheimer Care, Industry |
| Collaborators | Abbott Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Dementia |
| Intervention type | Drug |
| Interventions | Depakote |
| Enrollment | 20 |
| Start date | Mar 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 15, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: